Get started
RocketTickers

Immunomedics Announces Positive Results from Phase 3 ASCENT Stud

Long
RocketTickers  
NASDAQ:IMMU   None
Beyond Technical Analysis
3
0
beyondta
IMMU: Immunomedics
2020-07-06 07:55:10
Immunomedics Announces Positive Results from Phase 3 ASCENT Study of TRODELVY™ in Previously-Treated Patients with Metastatic Triple-Negative Breast Cancer (mTNBC)
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.